Evidence map›Paper›PMID 39558528›Full record

ArticleJournal of chemical information and modeling2024

Transparent Machine Learning Model to Understand Drug Permeability through the Blood-Brain Barrier.

Hengjian Jia, Gabriele C Sosso

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hengjian JiaDepartment of Chemistry, University of Warwick, Coventry CV1 1DT, U.K.ORCID 0009-0006-4830-1883
Gabriele C SossoDepartment of Chemistry, University of Warwick, Coventry CV1 1DT, U.K.ORCID 0000-0002-6156-7399

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The blood-brain barrier (BBB) selectively regulates the passage of chemical compounds into and out of the central nervous system (CNS). As such, understanding the permeability of drug molecules through the BBB is key to treating neurological diseases and evaluating the response of the CNS to medical treatments. Within the last two decades, a diverse portfolio of machine learning (ML) models have been regularly utilized as a tool to predict, and, to a much lesser extent, understand, several functional properties of medicinal drugs, including their propensity to pass through the BBB. However, the most numerically accurate models to date lack in transparency, as they typically rely on complex blends of different descriptors (or features or fingerprints), many of which are not necessarily interpretable in a straightforward fashion. In fact, the "black-box" nature of these models has prevented us from pinpointing any specific design rule to craft the next generation of pharmaceuticals that need to pass (or not) through the BBB. In this work, we have developed a ML model that leverages an uncomplicated, transparent set of descriptors to predict the permeability of drug molecules through the BBB. In addition to its simplicity, our model achieves comparable results in terms of accuracy compared to state-of-the-art models. Moreover, we use a naive Bayes model as an analytical tool to provide further insights into the structure-function relation that underpins the capacity of a given drug molecule to pass through the BBB. Although our results are computational rather than experimental, we have identified several molecular fragments and functional groups that may significantly impact a drug's likelihood of permeating the BBB. This work provides a unique angle to the BBB problem and lays the foundations for future work aimed at leveraging additional transparent descriptors, potentially obtained via bespoke molecular dynamics simulations.

Indexed as

Blood-Brain BarrierMachine LearningPermeabilityHumansModels, BiologicalPharmaceutical PreparationsPharmaceutical Preparations

Identifiers

PMID39558528
PMCPMC11632763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.